Differin 0.1% cream

Страна: Велика Британія

мова: англійська

Джерело: MHRA (Medicines & Healthcare Products Regulatory Agency)

Активний інгредієнт:

Adapalene

Доступна з:

DE Pharmaceuticals

Код атс:

D10AD03

ІПН (Міжнародна Ім'я):

Adapalene

Дозування:

1mg/1gram

Фармацевтична форма:

Cutaneous cream

Адміністрація маршрут:

Cutaneous

Клас:

No Controlled Drug Status

Тип рецепту:

Valid as a prescribable product

Огляд продуктів:

BNF: 13060100

інформаційний буклет

Galderma-Differin-UK-Cream
Galderma-Differin-UK-Cream

Характеристики продукта

1. NAME OF THE MEDICINAL PRODUCT
Differin
0.1% w/w Cream
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
Adapalene 0.1% w/w
1g cream contains 1mg adapalene.
Excipients with known effect:
Methyl parahydroxybenzoate (E218)
Propyl parahydroxybenzoate (E216)
For the full list of excipients, see section 6.1
3. PHARMACEUTICAL FORM
Cream
White shiny cream
4. CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
_ _
Differin Cream is proposed for the cutaneous treatment of mild to
moderate acne vulgaris where
comedones, papules and pustules predominate. Differin Cream is best
suited for use on dry and fair skin.
Acne of the face, chest or back is appropriate for treatment. _ _
4.2
POSOLOGY AND METHOD OF ADMINISTRATION_ _
Differin Cream should be applied to the acne affected areas once a day
before retiring and after washing.
A thin film of cream should be applied, with the fingertips, avoiding
the eyes and lips (see 4.4 _Special _
_warnings and special precautions for use_, below). Ensure that the
affected areas are dry before
application.
Since it is customary to alternate therapies in the treatment of acne,
it is recommended that the physician
assess the continued improvement of the patient after three months of
treatment with Differin Cream.
With patients for whom it is necessary to reduce the frequency of
application or to temporarily
discontinue treatment, frequency of application may be restored or
therapy resumed once it is judged
that the patient can again tolerate the treatment.
If patients use cosmetics, these should be non-comedogenic and
non-astringent.
_Paediatric population:_ The safety and effectiveness of Differin
Cream have not been studied in children
below 12 years of age.
1.1
4.3 CONTRAINDICATIONS
Pregnancy (see section 4.6).
Women planning a pregnancy.
Hypersensitivity to the active substance or to any of the excipients
listed in section 6.1.
4.4
SPECIAL WARNINGS AND PRECAUTIONS FOR USE
If a reaction suggesting sensitivity or severe irritation occurs, use
of the medication should be
discontinued. If the degre